Ultragenyx Pharmaceutical Inc. · NASDAQ:RARE
Crombez Eric received 34,674 Ultragenyx Pharmaceutical Inc. shares as an award (Form 4)
Traded Apr 16, 2026 · Filed Apr 20, 2026
On Apr 16, 2026, Crombez Eric (EVP and Chief Medical Officer) received 34,674 Ultragenyx Pharmaceutical Inc. shares as an award, leaving 110,975 shares. Filed Apr 20, 2026 (Form 4).
- Awarded
- 34,674 shares
- Holding after
- 110,975 shares
- Trading plan
- No
- Role
- EVP and Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 16, 2026 | Common Stock | Award | 34,674 | 110,975 | Direct |
Source
Related
- Ultragenyx Pharmaceutical Inc.
- Crombez Eric
- Ultragenyx Pharmaceutical Inc. shareholders
- Form 4 · Crombez Eric · May 6, 2026
- Schedule 13G · Madison Avenue Partners, LP · Oct 20, 2026
- Form 4 · Horn Howard · Oct 19, 2026
- Form 4 · Huizenga Theodore Alan · Sep 15, 2026
- Form 4 · Huizenga Theodore Alan · Sep 8, 2026
- Schedule 13G · Rtw Investments, LP · Aug 14, 2026